ÍøºìºÚÁÏ

Skip to main content
(352) 273-8740

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ali Ataya
(352) 273-8740 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Pulmonary Alveolar Proteinosis , 4 publications
  • Lymphangioleiomyomatosis , 4 publications
  • Fever , 4 publications

Research activity

122 publications

396 citations

Why is this important?

Active clinical trials

United therapeutics 301

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World ÍøºìºÚÁÏ Organization (WHO)…

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Sapphire

This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 99 Years
Sexes
All

My publications

122 publications

2025

A patient journey map for people living with autoimmune pulmonary alveolar proteinosis

Respiratory Medicine

2025

Case report: Novel homozygous ACVRL1 missense variant in a family with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension: findings suggest a hypomorphic allele.

Frontiers in genetics

•

2025

Concurrent limited cutaneous systemic sclerosis and hereditary haemorrhagic telangiectasia.

The Lancet. Haematology

•

2025

Development of New Intrapulmonary Shunts in Pulmonary Arterial Hypertension Patients Treated with Sotatercept

American Journal of Respiratory and Critical Care Medicine

2025

Glycogen storage disease type V: delayed diagnosis of a cause of exercise intolerance in a patient with hereditary haemorrhagic telangiectasia.

BMJ case reports

•